Advertisement
Advertisement
U.S. Markets open in 6 hrs 44 mins
S&P Futures
3,915.75 -0.50 (-0.01%) Dow Futures
31,480.00 -7.00 (-0.02%) Nasdaq Futures
12,142.25 +1.75 (+0.01%) Russell 2000 Futures
1,761.40 -0.30 (-0.02%) Crude Oil
107.50 -0.12 (-0.11%) Gold
1,837.90 +7.60 (+0.42%)
Marinus Pharmaceuticals, Inc. (MRNS)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 5.0900 |
| Open | 5.1500 |
| Bid | 0.0000 x 900 |
| Ask | 0.0000 x 800 |
| Day's Range | 4.7500 - 5.1750 |
| 52 Week Range | 3.9700 - 19.3970 |
| Volume | |
| Avg. Volume | 345,991 |
| Market Cap | 183.488M |
| Beta (5Y Monthly) | 1.33 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.4790 |
| Earnings Date | Mar 07, 2022 - Mar 11, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 30.56 |
- Simply Wall St.
What Type Of Shareholders Make Up Marinus Pharmaceuticals, Inc.'s (NASDAQ:MRNS) Share Registry?
A look at the shareholders of Marinus Pharmaceuticals, Inc. ( NASDAQ:MRNS ) can tell us which group is most powerful...
- Business Wire
Marinus Pharmaceuticals Expands Enrollment Criteria to Support Recruitment in Phase 3 RAISE Trial in Refractory Status Epilepticus
RADNOR, Pa., June 08, 2022--Marinus Pharmaceuticals Expands Enrollment Criteria to Support Recruitment in Phase 3 RAISE Trial in Refractory Status Epilepticus
- Business Wire
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
RADNOR, Pa., June 03, 2022--Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
